TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33406539

Group type: EXPERIMENTAL
Intervention: Delayed umbilical cord clamping
Number of subjects: 180

Group type: COMPARATOR
Intervention: Umbilical cord milking
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Gestational age (GA)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Small for gestational age (SGA) infants
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Birth weight
Number of subjects: 180
Study: 35655280

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 287

Group type: COMPARATOR
Intervention: Non-surgical treatment
Number of subjects: 287
Study: 32591406

Group type: EXPERIMENTAL
Intervention: Flat head position (FP)
Number of subjects: 867
Study: 36031952

Group type: EXPERIMENTAL
Intervention: Pharmacist-led educational intervention
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 128
Study: 34242246

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) monotherapy
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Tumor necrosis factor inhibitors (TNFi) in combination with MTX
Number of subjects: 39
Study: 32358482

Group type: EXPERIMENTAL
Intervention: LGI 2 biscuits (GI 24)
Number of subjects: 13

Group type: COMPARATOR
Intervention: LGI 1 biscuits (GI 54)
Number of subjects: 13
Study: 35856483

Group type: EXPERIMENTAL
Intervention: Dermapen and topical coconut oil
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dermapen and topical sesame oil
Number of subjects: 24

Group type: COMPARATOR
Intervention: Periodontal mechanical treatment only
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 24
Study: 33058259

Group type: EXPERIMENTAL
Intervention: Indoor wood smoke reduction intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 0
Study: 33993790

Group type: EXPERIMENTAL
Intervention: modified dynamic needle tip positioning short-axis
Number of subjects: 90

Group type: COMPARATOR
Intervention: long-axis
Number of subjects: 90
Study: 32122703

Group type: EXPERIMENTAL
Intervention: Photobiomodulation treatment (GaAs diode laser, continuous wave 980nm, power 100mW, energy density 12J/cm2, applied on days 1, 3, 7, 14, 21, and 28 postoperatively)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Photobiomodulation treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control side (laser probe turned off)
Number of subjects: 18
Study: 36327046

Group type: EXPERIMENTAL
Intervention: Wuqinxi exercise (60 min/session, once a week for 40 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-exercise control group
Number of subjects: 50
Study: 33793678

Group type: EXPERIMENTAL
Intervention: Combination of antiviral and nonsteroidal anti-inflammatory treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32811529

Group type: EXPERIMENTAL
Intervention: Rural mothers
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Mothers with no formal education
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Overall U5 children with fever
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Mothers with poor malaria knowledge
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Mothers with poor perception of malaria
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: Household size > 5
Number of subjects: 630
Study: 34816478

Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment and Hall Technique (ART/HT)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 338
Study: 35264075

Group type: EXPERIMENTAL
Intervention: Prebiotic-rich yogurt (100g daily for 6 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular yogurt (control)
Number of subjects: 60
Study: 32208178

Group type: EXPERIMENTAL
Intervention: Community Engagement Studio (CE Studio)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Educational videos created in response to parental comments
Number of subjects: 13
Study: 36450626

Group type: COMPARATOR
Intervention: cobimetinib (cobi) 60 mg/day on days 1-21
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: cobimetinib (cobi) 40 mg/day on days 1-21 + venetoclax (ven) 800 mg/day on days 1-28
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: cobimetinib (cobi) 40 mg/day on days 1-21 + venetoclax (ven) 800 mg/day on days 1-28 + atezolizumab (atezo) 840 mg on days 1 and 15 of 28-day cycles
Number of subjects: 49
Study: 34772434

Group type: EXPERIMENTAL
Intervention: Caregiver educational intervention based on the Integrative Model of Behavioral Prediction (IMBP)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Supplementary low-protein-modified foods
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Caregiver educational intervention
Number of subjects: 46
Study: 32679370

Group type: EXPERIMENTAL
Intervention: Caffeine treatment
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 194
Study: 35625055

Group type: EXPERIMENTAL
Intervention: Dynamic sitting exercise with 500-ms-delayed visual feedback (30 times/day, 5 days/week)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Dynamic sitting exercise with 500-ms-delayed visual feedback
Number of subjects: 27

Group type: COMPARATOR
Intervention: Real-time visual feedback (control group)
Number of subjects: 27
Study: 32536150

Group type: EXPERIMENTAL
Intervention: Lopinavir-ritonavir
Number of subjects: 65

Group type: COMPARATOR
Intervention: Hydroxychloroquine
Number of subjects: 65
Study: 35902299

Group type: EXPERIMENTAL
Intervention: Clomiphene with acupuncture
Number of subjects: 1000
Study: 34375706

Group type: EXPERIMENTAL
Intervention: Major infection group (patients who experienced major infections)
Number of subjects: 1517

Group type: COMPARATOR
Intervention: No major infection group (patients who did not experience major infections)
Number of subjects: 1517

Group type: EXPERIMENTAL
Intervention: Major infection group (with periprocedural major infections)
Number of subjects: 1517

Group type: COMPARATOR
Intervention: No major infection group (without periprocedural major infections)
Number of subjects: 1517
Study: 35766041

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) goal <120 mm Hg
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard systolic blood pressure (SBP) goal <140 mm Hg
Number of subjects: 9361
Study: 34584881

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil combined with Xingpi Yanger granules
Number of subjects: 124
Study: 32586153

Group type: EXPERIMENTAL
Intervention: Invasive strategy with coronary angiography and optimal medical treatment
Number of subjects: 186

Group type: COMPARATOR
Intervention: Conservative strategy with only optimal medical treatment
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 186
Study: 32052831

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 250 mg intramuscular single dose and doxycycline for 14 days plus metronidazole for 14 days
Number of subjects: 233

Group type: COMPARATOR
Intervention: Ceftriaxone 250 mg intramuscular single dose and doxycycline for 14 days
Number of subjects: 233
Study: 34489276

Group type: EXPERIMENTAL
Intervention: del Nido
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: modified del Nido
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Custodiol
Number of subjects: 90
Study: 35713267

Group type: EXPERIMENTAL
Intervention: IIP + CTG
Number of subjects: 30

Group type: COMPARATOR
Intervention: IIP
Number of subjects: 30
Study: 34258686

Group type: EXPERIMENTAL
Intervention: Continuous antibiotic infusion (CAI) via an ambulatory pump
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard pump and intermittent antibiotic administration (IAA)
Number of subjects: 40
Study: 32514012

Group type: EXPERIMENTAL
Intervention: AT2R
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Klf‐5/IRF‐1 and circErbB4/miR-29a-5p
Number of subjects: 0
Study: 34962679

Group type: EXPERIMENTAL
Intervention: Unused healing abutment
Number of subjects: 72

Group type: COMPARATOR
Intervention: Reused healing abutment
Number of subjects: 72
Study: 33253659

Group type: EXPERIMENTAL
Intervention: Extensive intraoperative peritoneal lavage (EIPL) with 1 L of warm normal 0.9% saline, repeated ten times after surgery.
Number of subjects: 800

Group type: COMPARATOR
Intervention: Standard surgery (surgery alone).
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: EIPL group (adverse events).
Number of subjects: 800

Group type: COMPARATOR
Intervention: Standard surgery group (adverse events).
Number of subjects: 800
Study: 33583347

Group type: EXPERIMENTAL
Intervention: Temporarily Hostile (TH) group, primed with negative words
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Temporarily Non-Hostile (TNH) group, primed with positive words
Number of subjects: 38
Study: 32252697

Group type: EXPERIMENTAL
Intervention: Group A (81±5.5 years)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Group B (44±3.2 years)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Group C (21±2.5 years)
Number of subjects: 78
Study: 36058253

Group type: EXPERIMENTAL
Intervention: Mechanical LV unloading with the Impella CP device for 30 minutes prior to primary PCI
Number of subjects: 668

Group type: COMPARATOR
Intervention: Primary PCI alone without LV unloading
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: Impella CP-related major bleeding or major vascular complications within 30 days
Number of subjects: 668
Study: 34327527

Group type: EXPERIMENTAL
Intervention: Percutaneous mechanical circulatory support (pMCS) by Impella CP
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Percutaneous mechanical circulatory support (pMCS)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups (pMCS and IABP)
Number of subjects: 48
Study: 32303763

Group type: EXPERIMENTAL
Intervention: ALM 100 mg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: ALM 200 mg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: ZOL 10 mg
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 34841598

Group type: EXPERIMENTAL
Intervention: SUB group (n=18) - substituted pecans for isocaloric foods from their habitual diet
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: ADD group (n=16) - consumed pecans as part of a free‐living diet
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (n=18) - nut-free
Number of subjects: 56
Study: 34950734

Group type: EXPERIMENTAL
Intervention: Pictorial intervention
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study: 33915514

Group type: EXPERIMENTAL
Intervention: Severe to profound preoperative hearing loss (PTA > 70 dB HL)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group with preoperative serviceable hearing
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Preoperative profound hearing loss
Number of subjects: 57
Study: 32232781

Group type: EXPERIMENTAL
Intervention: Longitudinal low‐frequency, high‐intensity direct observation and coaching intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual precepting
Number of subjects: 100
Study: 35742357

Group type: EXPERIMENTAL
Intervention: Tropocollagen gel treatment (group A, n = 47)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo alone (group B, n = 45)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 100
Study: 32214517

Group type: EXPERIMENTAL
Intervention: Asenapine
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 34491449

Group type: EXPERIMENTAL
Intervention: Rebilda DC (RDC)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Clearfil DC Core (CDC)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Multicore Flow (MF)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Overall failure rate
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Larger cavities (>3 surfaces)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Treatment by dental students
Number of subjects: 300
Study: 33218384

Group type: EXPERIMENTAL
Intervention: Tube first technique
Number of subjects: 16

Group type: COMPARATOR
Intervention: Video laryngoscope technique
Number of subjects: 16
Study: 34888663

Group type: EXPERIMENTAL
Intervention: Soluble corn fiber (SCF) 20 g/day for 2 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Maltodextrin placebo
Number of subjects: 20
Study: 33328324

Group type: EXPERIMENTAL
Intervention: siponimod 2 mg/d
Number of subjects: 1651

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1651
Study: 32909497

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg daily
Number of subjects: 250
Study: 36429761

Group type: EXPERIMENTAL
Intervention: Extended restart breaks (from 31 h to 55 h) after consecutive night shifts
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control condition (standard restart breaks)
Number of subjects: 30
Study: 33922783

Group type: EXPERIMENTAL
Intervention: Caffeine loading 40 mg/kg/day and maintenance 20 mg/kg/day
Number of subjects: 78

Group type: COMPARATOR
Intervention: Caffeine loading 20 mg/kg/day and maintenance 10 mg/kg/day
Number of subjects: 78
Study: 32985341

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 155 U every 12 weeks
Number of subjects: 282

Group type: COMPARATOR
Intervention: Topiramate 50 to 100 mg/day
Number of subjects: 282
Study: 32877791

Group type: EXPERIMENTAL
Intervention: Mother-taught program (two-hour workshop and Body Safety Training workbook)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 56
Study: 34783882

Group type: EXPERIMENTAL
Intervention: Single-joint hybrid assistive limb (HAL-SJ)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Continuous passive motion (CPM)
Number of subjects: 34
Study: 34183053

Group type: EXPERIMENTAL
Intervention: NIV alternating with high-flow nasal oxygen
Number of subjects: 146

Group type: COMPARATOR
Intervention: High-flow nasal oxygen alone
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: NIV
Number of subjects: 146
Study: 36205549

Group type: EXPERIMENTAL
Intervention: Red wine (RW) consumption (250 mL/d, 5 d/wk for 3 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Alcohol abstention (for 3 weeks)
Number of subjects: 42
Study: 34871046

Group type: EXPERIMENTAL
Intervention: 7 days of ciprofloxacin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7 days of trimethoprim-sulfamethoxazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: 14 days of antibiotic therapy
Number of subjects: 0
Study: 35289895

Group type: EXPERIMENTAL
Intervention: High-flow oxygen therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 0
Study: 33144086

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 240
Study: 32416996

Group type: EXPERIMENTAL
Intervention: Liberal benzodiazepine use
Number of subjects: 800

Group type: COMPARATOR
Intervention: Restricted benzodiazepine use
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Postoperative delirium assessment
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Intraoperative awareness assessment
Number of subjects: 800
Study: 34422166

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention using an audio-visual tool
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 138
Study: 32340155

Group type: EXPERIMENTAL
Intervention: Computerized cognitive training intervention with lab-based tasks, specific dosage and duration not mentioned.
Number of subjects: 0
Study: 34811957

Group type: EXPERIMENTAL
Intervention: Convolutional neural network (CNN) model for auto-segmentation of clinical target volume (CTV)
Number of subjects: 155

Group type: COMPARATOR
Intervention: AI model (CNN)
Number of subjects: 155
Study: 34899426

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dialectical Behavior Therapy (DBT‐bt)
Number of subjects: 60
Study: 35954975

Group type: EXPERIMENTAL
Intervention: Specific psychoeducation about MBPs for mental health
Number of subjects: 188

Group type: COMPARATOR
Intervention: General psychoeducation about psychological treatments for mental health
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Both specific and general psychoeducation
Number of subjects: 188
Study: 34960005

Group type: EXPERIMENTAL
Intervention: Medical Nutrition Therapy (MNT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group with standard advice
Number of subjects: 48
Study: 32147880

Group type: EXPERIMENTAL
Intervention: Peptide 1 (11-residue peptide tagged with rhodamine fluorophore)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Peptide 2 (randomized sequence of Peptide 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peptide 1
Number of subjects: 0
Study: 36036731

Group type: EXPERIMENTAL
Intervention: ADD group (n=15) consuming pecans (68 g) as part of a free-living diet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SUB group (n=16) substituting pecans (68 g) for isocaloric foods from their habitual diet
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (nut-free, n=16)
Number of subjects: 16
Study: 33794182

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted darunavir with raltegravir
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted darunavir with tenofovir disoproxil fumarate and emtricitabine
Number of subjects: 168

Group type: COMPARATOR
Intervention: After 2 years of ART (both regimens)
Number of subjects: 168
Study: 35166174

Group type: EXPERIMENTAL
Intervention: Black PWH
Number of subjects: 40

Group type: COMPARATOR
Intervention: White PWH
Number of subjects: 40
Study: 34155899

Group type: EXPERIMENTAL
Intervention: ceftobiprole
Number of subjects: 0

Group type: COMPARATOR
Intervention: comparators
Number of subjects: 0
Study: 35667721

Group type: EXPERIMENTAL
Intervention: Immediate initiation of anti-TB therapy
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Sepsis-specific dose anti-TB therapy
Number of subjects: 436

Group type: COMPARATOR
Intervention: Standard of care antibacterials
Number of subjects: 436
Study: 33588893

Group type: EXPERIMENTAL
Intervention: Intravenous iron (1 g of ferric carboxymaltose) when hepcidin < 20 μg/l and intravenous iron and erythropoietin for 20 ≤ hepcidin < 41 μg/l.
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Intravenous iron treatment according to hepcidin levels.
Number of subjects: 399

Group type: COMPARATOR
Intervention: Standard care (hepcidin quantification remained blinded).
Number of subjects: 399
Study: 34059361

Group type: EXPERIMENTAL
Intervention: MI-based education
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 98
Study: 34039329

Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deep Belief Network (DBN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic Algorithm - Decision Tree (GA-DT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three-layer back propagation neural network (BPNN)
Number of subjects: 0
Study: 34709668

Group type: EXPERIMENTAL
Intervention: Lemon oil
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Non-scented grapeseed oil
Number of subjects: 59

Group type: COMPARATOR
Intervention: Pure deionized water
Number of subjects: 59

Group type: COMPARATOR
Intervention: Particulate matter with HEPA filters
Number of subjects: 59
Study: 32982226

Group type: EXPERIMENTAL
Intervention: TfR‐T12‐PEG‐PLA/PTX polymeric micelles (TfR‐T12‐PMs)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Unmodified PMs
Number of subjects: 2
Study: 33509678

Group type: EXPERIMENTAL
Intervention: Dabigatran with O-A time <8 h
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Dabigatran with O-A time 8–24 h
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Dabigatran with O-A time >24 h
Number of subjects: 535
Study: 32026393

Group type: EXPERIMENTAL
Intervention: FFC (formoterol/fluticasone aerosol, pMDI)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: FBC (formoterol/budesonide dry powder inhaler, DPI)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: VFC (vilanterol/fluticasone furoate dry powder inhaler, DPI)
Number of subjects: 15
Study: 33891907

Group type: EXPERIMENTAL
Intervention: Full-dose anticoagulation with rivaroxaban 20 mg once daily (or full-dose heparin if oral administration is not feasible) for 30 days
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard of care with any approved venous thromboembolism prophylaxis regimen during hospitalization
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Full-dose anticoagulation with rivaroxaban or enoxaparin followed by rivaroxaban through 30 days
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Full-dose anticoagulation with rivaroxaban or enoxaparin
Number of subjects: 600
Study: 33302991

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 21
Study: 35156255

Group type: EXPERIMENTAL
Intervention: MB@QP-PDT
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: MB-PDT
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (NaOCl)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Er,Cr:YSGG laser
Number of subjects: 9
Study: 34544560

Group type: EXPERIMENTAL
Intervention: Methods-Motivational Interviewing approach with prerequisite orientations
Number of subjects: 800